Colin Steele currently serves as Vice President of Therapeutics, Diagnostics, and Insights at Dexcom, having joined the company in 2018 after Dexcom's acquisition of TypeZero. With extensive experience in leadership roles, Colin has previously held positions such as Chief Technology Officer at TypeZero Technologies and CTO at hotelicopter, providing strategic direction and developing innovative technology solutions. Colin's consulting work since 2000 includes executive-level services for early-stage and struggling companies. Educational qualifications include a BA in Mathematics from the College of the Holy Cross.
This person is not in any teams
This person is not in any offices